Cisco, Intel, Microsoft: Dow Movers
NEW YORK (TheStreet) '" U.S. stocks fell Thursday as concerns about a global economic slowdown weighed on investor sentiment.
The Dow Jones Industrial Average dropped 31 points, or 0.25%, to close at 12,573.
Breadth within the Dow was negative with 22 of the 30 components posting losses. Tech heavyweights Cisco (CSCO), Intel (INTC) and Microsoft (MSFT) posted the biggest percentage declines.
Shares of Cisco dropped 2.44% to $15.98. The stock has fallen 11.62% year to date.
Intel shares lost 2.56% to $24.74. The stock has risen 2.02% year to date. Shares of Microsoft fell 2.29% to $28.63. The stock has risen 10.29% year to date. The biggest percentage gainers were Merck (MRK) and Procter & Gamble (PG), both up about 4%. Shares of Merck gained 4.13% to $42.91 after the drug giant concluded a late-stage trial of an osteoporosis drug because of the study's strong results. "The Data Monitoring Committee (DMC) for the study recently completed its first planned interim analysis for efficacy and recommended that the study be closed early due to robust efficacy and a favorable benefit-risk profile," the Whitehouse Station, N.J.-based company said in a press release. Merck now plans to file applications for regulatory approval of the drug in the United States, European Union and Japan in the first half of 2013. Citigroup upgraded Merck to buy with a $50 price target following the news. Shares of P&G jumped 3.75% to $63.70 following media reports that Bill Ackman's Pershing Square investment firm is building a stake in the consumer products giant. --Written by Alexandra Zendrian in New York.>To contact the writer of this article, click here: Alexandra Zendrian >To submit a news tip, send an email to: tips@thestreet.com. >To follow the writer on Twitter, go to Alexandra Zendrian.
Select the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
TheStreet Quant Ratings
TRY IT FREENew! $49.95/yr
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
Product Features:
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Dividend Stock Advisor
TRY IT FREEJim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV